Atlas Trials

Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

Clinical trial NCT00051038 · COMPLETED

Trial details

NCT number
NCT00051038
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatitis B
Start date
2002-09-01
Primary completion
2005-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.